Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results
Appointed director

BIODESIX INC (BDSX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/23/2023 4 SCHULER JACK W (10% Owner) has filed a Form 4 on BIODESIX INC
Txns: Bought 32,556 shares @ $1.6406, valued at $53.4k
Bought 8,307 shares @ $1.6683, valued at $13.9k
Bought 87,500 shares @ $1.7056, valued at $149.2k
08/11/2023 4 SCHULER JACK W (10% Owner) has filed a Form 4 on BIODESIX INC
Txns: Granted 9,989,506 shares @ $1.62, valued at $16.2M
08/11/2023 SC 13D/A SCHULER JACK W reports a 32.1% stake in Biodesix, Inc.
08/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/09/2023 144 Form 144 - Report of proposed sale of securities:
08/07/2023 4 Watts Charles M (Director) has filed a Form 4 on BIODESIX INC
Txns: Granted 12,345 shares @ $1.62, valued at $20k
08/07/2023 4 Vazquez Chris (Chief Accounting Officer) has filed a Form 4 on BIODESIX INC
Txns: Granted 617 shares @ $1.62, valued at $999.5
08/07/2023 4 Strobeck Matthew (Director) has filed a Form 4 on BIODESIX INC
Txns: Granted 127,777 shares @ $1.62, valued at $207k
Granted 6,790 shares @ $1.62, valued at $11k
Granted 140,123 shares @ $1.62, valued at $227k
Granted 13,580 shares @ $1.62, valued at $22k
08/07/2023 4 Pestano Gary Anthony (Chief Development Officer) has filed a Form 4 on BIODESIX INC
Txns: Granted 617 shares @ $1.62, valued at $999.5
08/07/2023 4 PATIENCE JOHN (10% Owner) has filed a Form 4 on BIODESIX INC
Txns: Granted 61,728 shares @ $1.62, valued at $100k
08/07/2023 4 O'Kane Kieran (Chief Commercial Officer) has filed a Form 4 on BIODESIX INC
Txns: Granted 6,172 shares @ $1.62, valued at $10k
08/07/2023 4 MASSARANY HANY (Director) has filed a Form 4 on BIODESIX INC
Txns: Granted 30,864 shares @ $1.62, valued at $50k
08/07/2023 4 Kennedy Lawrence T. Jr (10% Owner) has filed a Form 4 on BIODESIX INC
Txns: Granted 6,172,839 shares @ $1.62, valued at $10M
08/07/2023 4 Kayyem Jon Faiz (Director) has filed a Form 4 on BIODESIX INC
Txns: Granted 6,172 shares @ $1.62, valued at $10k
08/07/2023 4 Hutton Scott (President & CEO) has filed a Form 4 on BIODESIX INC
Txns: Granted 46,296 shares @ $1.62, valued at $75k
08/07/2023 4 Cowie Robin Harper (CFO, Sec'y & Treasurer) has filed a Form 4 on BIODESIX INC
Txns: Granted 6,172 shares @ $1.62, valued at $10k
08/07/2023 4 Franchi Jean M. (Director) has filed a Form 4 on BIODESIX INC
Txns: Granted 61,728 shares @ $1.62, valued at $100k
08/07/2023 SC 13D/A PATIENCE JOHN reports a 7.9% stake in Biodesix, Inc.
08/07/2023 SC 13D/A Kennedy Lawrence T. Jr reports a 22% stake in Biodesix, Inc.
08/07/2023 8-K Quarterly results
Docs: "Biodesix Announces Second Quarter 2023 Results and Highlights Second quarter 2023 Core Lung Diagnostic revenue of $11.4 million increased 58% over the comparable period in 2022 and 33% over the first quarter of 2023; Second quarter 2023 gross profit margin of 73% versus 64% for the second quarter 2022 and 65% for the first quarter 2023; Revenue continues to track to 2023 full year guidance of $52-55 million; Approximately $27.5 million in common shares sold under a private placement from the Company’s largest investors, Board of Directors members, and Executive Leadership team; Multiple publications and data presentations on the clinical utility and health economic benefits of Core Lung Diagnostics tests; Conference Call and Webcast Today at 4:30 p.m. ET BOULDER, CO, August 7, 2023 –"
07/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/26/2023 8-K Quarterly results
07/26/2023 SC TO-I/A Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
07/06/2023 3 Vazquez Chris (Chief Accounting Officer) has filed a Form 3 on BIODESIX INC
07/03/2023 SC TO-I/A Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
06/06/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy